APT Medical Q1 Profit Rises 31%; Shares Down 5%

APT Medical's net profit attributable to shareholders in 2024 rose 26% to 673.2 million yuan from 533.9 million yuan a year earlier, according to a Wednesday filing with the Shanghai Stock Exchange.

Earnings per share climbed 27% year on year to 6.92 yuan from 5.46 yuan.

The Chinese medical device company's operating income in the same period inched 25% higher to 2.07 billion yuan from 1.65 billion yuan in the previous year, the filing said.

The company's shares dropped 4% in recent trade.

APT Medical's net profit attributable to shareholders in 2024 rose 26% to 673.2 million yuan from 533.9 million yuan a year earlier, according to a Wednesday filing with the Shanghai Stock Exchange.

Earnings per share climbed 27% year on year to 6.92 yuan from 5.46 yuan.

The Chinese medical device company's operating income in the same period inched 25% higher to 2.07 billion yuan from 1.65 billion yuan in the previous year, the filing said.

The company's shares dropped 4% in recent trade.

APT Medical , through a subsidiary, obtained a medical device registration certificate from the Chinese drug administration for its vena cava filter system, according to a Wednesday filing with the Shanghai Stock Exchange.

The device is inserted through the femoral vein or jugular vein to prevent pulmonary embolism, the medical device company said.

APT Medical subsidiary Hunan Apt Medical Device obtained a medical device registration certificate for its disposable magnetic positioning pressure monitoring radiofrequency ablation catheter.

The device provides information on the location of the catheter in the heart, according to a Thursday filing with the Shanghai bourse.

Shares of the company were down 1% in recent trade.